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Energy requirements in endothelial cells are relatively low, and
glycolysis is the major source of ATP production. For these reasons,
the mitochondria of endothelial cells have been somewhat neglected.
Recently it was discovered that mitochondria, and especially mito-
chondria in endothelial cells, predominantly function in signalling
cellular responses to environmental signals. Important modes of
mitochondrial signalling in endothelial cells are the regulated pro-
duction of reactive oxygen species (ROS) and signalling, autophagy,
calcium homeostasis, apoptosis, and heme biosynthesis. It is now clear
that mitochondria are important in endothelial physiology and
pathophysiology. It is also well documented that inﬂammation is a
key factor that accelerates the onset and progression of atherosclero-
sis. In our study we have investigated the role of endothelial cell
mitochondria in regulation of ROS and NO production, and inﬂam-
matory response. As amodel ofmitochondrial dysfunction endothelial
cells EA.hy 926 modiﬁed with 2′,3′-Dideoxycytidine (ddc) were
used. Inﬂammation was stimulated with tumour necrosis factor alpha
(TNF-alpha) in dose and time dependent manner. The ROS and NO
production were measured using ﬂuorescence dyes methods. Inter-
cellular adhesion molecule 1 (ICAM-1) expression in normal and
modiﬁed endothelial cells were detected using confocal microscopy,
ﬂow cytometry, ﬂuorescence techniques at protein level and real time
PCR atmRNA level.We demonstrated that EA.hy 926 cells treatedwith
ddc were entirely lacking of oxygen consumption on basal and FCCP
stimulated level. The level of ROS production was statistically higher
in ddc treated cells in comparison to control as measured with DCF
(2′,7′-dichloroﬂuorescein diacetate) and mitoSOX. The inner mito-
chondrial membrane potential was lower in ddc treated cells than in
control cells. The TNF-α stimulated ICAM-1 synthesis, as a marker of
inﬂammation, was lower in ddc treated EA.hy 926 cells on protein
and mRNA levels. We propose that mitochondria in endothelial
cells are potent target in modulation of inﬂammatory processes. This
study was supported by the European Union with resources from the
European Regional Development Fund under the Innovative Economy
Programme (POIG.01.01.02-00-069/09).
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Hypoxia inducible factors (HIF-1/2) signalling brings together
mitochondrial, cancer and hypoxia research. Hypoxia is often associated
with cancer, however even at non-restricted O2 supply certain mito-
chondrial abnormalities trigger HIF pathways andmetabolic rearrange-
ments for cancer development [1]. However, alterations in HIF
signalling only partly explain the dramatic changes in mitochondrial
function and cancer development. Using dimethyloxaloylglycine
(DMOG), a cell-permeable compound structurally similar to α-
ketoglutarate and fumarate and potent activator of HIF, we found
that early inhibitory effect of this drug on the mitochondria is HIF-
independent. Pre-treatment of PC12 and HCT116 cells with 0.5 mM
DMOG for 0.5 h noticeably reduced mitochondrial respiration and
activated glycolytic activity, measured using phosphorescent O2 and pH
sensors [2]. At this time–point the translation of HIF target genes was
not activated and could not contribute to the inhibition ofmitochondria.
Moreover, the effect of DMOG was not abolished in the presence of
a HIF inhibitor FM19G11. Exploring this ﬁnding further, we observed
pronounced remodelling of the mitochondrial network, composition,
size and proton gradients upon continuous exposure of cells to DMOG.
Such changes as an increase in mitochondrial size, elevation of VDAC1
and decrease in COXIV levels were not sensitive to FM19G11 treatment
and differed from that observed upon continuous hypoxia. Overall, our
results provide a new insight in the understanding of the mechanisms
underlying mitochondrial dysfunction.
This work was supported by grant SFI 12/RC/2276.
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Adult-onset deﬁciency of thyroid hormones causes a wide range of
nervous system dysfunctions, including impairments in learning and
memory. Nobiletin is a one of interesting ﬂavonoids that has neuropro-
tective and neurotrophic properties and affects the cognitive function of
brain. ATP synthesis, succinate dehydrogenase (SDH) andmitochondrial
hexokinase (mt-HK) activities in synaptic (SM) and cell mitochondria
(CM) of hippocampus of adult rats were compared among euthyroid,
hypothyroid, thyroxin (T4)-treated and nobiletin-supplemented hypo-
thyroid states. Decreased synthesis of ATP in hypothyroid rat hippo-
campus was observed in CM and SM, which was reversed by hormone
replacement, as well as by nobiletin administration. Oligomycin-
insensitive production of ATP, as well as α-ketoglutarate-dependent
production of ATP was also decreased in CM and SM of hypothyroid
animals and this reduction was not recovered after treatment of rats
by thyroxin in SM. Only the supplementation of nobiletin increases
oligomycin-insensitive and α-ketoglutarate-dependent production of
ATP in both types of mitochondria. SDH activity of hypothyroid rats
was lower in SM than in control rats, whereas SDH activity in CM of
hypothyroid rats exceeds the control level. The activity of SDH in CMwas
normalized after hormone replacement or nobiletin administration,
whereas in SM, only treatment of animals by T4 leads to the elevation of
SDH activity. Besides, we have found that in hypothyroid rats themt-HK
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activity, which was determined with exogenic ATP, is higher than in
control animals, whereas the enzyme's activity, which used endogenic
ATP is lower than in CM of control animals. In both cases, the HK activity
was normalized to the control levels after feeding of rats with nobiletin.
These data suggest that nobiletin could enhance mitochondrial ATP
synthesis in hypothyroidism through activation of matrix substrate-
level phosphorylation, which may be relevant for the prevention and
treatment of hypometabolic disorders.
doi:10.1016/j.bbabio.2014.05.029
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Ullrich Congenital Muscular Dystrophy (UCMD) and Bethlem
Myopathy (BM) are inherited muscle diseases due to mutations in
the genes encoding the extracellular matrix protein collagen (Col)
VI. Opening of the cyclosporin A-sensitive mitochondrial permeabil-
ity transition pore is a causative event in disease pathogenesis, and a
potential target for therapy. Here we have tested the effect of N-
methyl-4-isoleucine-cyclosporin (NIM811), a non-immunosuppressive
cyclophilin inhibitor, in a zebraﬁsh model of ColVI myopathy
obtained by deletion of the N-terminal region of the ColVI α1 triple
helical domain, a common mutation of UCMD. Treatment with
antisense morpholino sequences targeting col6a1 exon 9 at the 1–4
cell stage (within 1 hour post fertilization, hpf) caused severe
ultrastructural and motor abnormalities as assessed by electron
and ﬂuorescence microscopy, birefringence, spontaneous coiling
events and touch-evoked responses measured at 24–48 hpf. Struc-
tural and functional abnormalities were largely prevented when
NIM811 – which proved signiﬁcantly more effective and less toxic
than cyclosporin A –was administered at 21 hpf. Beneﬁcial effects of
NIM811 were also detected (i) in primary muscle-derived cell
cultures from UCMD and BM patients, where the typical mitochon-
drial alterations and depolarizing response to rotenone and
oligomycin were signiﬁcantly reduced; and (ii) in the Col6a1−/−
myopathic mouse model, where apoptosis was prevented and
muscle strength was increased. Since the permeability transition
pore of zebraﬁsh shares its key regulatory features with the
mammalian pore our results suggest that early treatment with
NIM811 should be tested as a potential therapy for UCMD and BM.
doi:10.1016/j.bbabio.2014.05.030
Abstractse78
